KCa1.1 channels as therapeutic targets for rheumatoid arthritis

被引：9
|
作者：
Beeton, Christine [1 ]
机构：
[1] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2017年 / 21卷 / 12期
关键词：
BK channel; synovial fibroblast; resident joint cells; rheumatoid arthritis; osteoarthritis; regulatory subunit; FIBROBLAST-LIKE SYNOVIOCYTES; K+ CHANNEL; POTASSIUM CHANNELS; LARGE-CONDUCTANCE; EXPRESSION; MECHANISM; PAXILLINE; SUBUNITS; EFFICACY; CELLS;
D O I：
10.1080/14728222.2017.1398234
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1077 / 1081
页数：5
相关论文
共 50 条
  • [41] Dysregulation of lncRNAs in Rheumatoid Arthritis: Biomarkers, Pathogenesis and Potential Therapeutic Targets
    Miao, Chenggui
    Bai, Liangliang
    Yang, Yaru
    Huang, Jinling
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] Current and novel therapeutic targets in the treatment of rheumatoid arthritis
    George, Genu
    Shyni, G. L.
    Raghu, K. G.
    INFLAMMOPHARMACOLOGY, 2020, 28 (06) : 1457 - 1476
  • [43] A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of Cav1.2 and KCa1.1 channels
    Carullo, Gabriele
    Ahmed, Amer
    Trezza, Alfonso
    Spiga, Ottavia
    Brizzi, Antonella
    Saponara, Simona
    Fusi, Fabio
    Aiello, Francesca
    BIOCHEMICAL PHARMACOLOGY, 2021, 185
  • [44] Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
    Bilski, Jan
    Schramm-Luc, Agata
    Szczepanik, Marian
    Mazur-Bialy, Agnieszka Irena
    Bonior, Joanna
    Luc, Kevin
    Zawojska, Klaudia
    Szklarczyk, Joanna
    BIOMEDICINES, 2023, 11 (11)
  • [45] Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?
    Sanchez-Lopez, Elsa
    Cheng, Anyan
    Guma, Monica
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [46] Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis
    Maney, Nicola J.
    Lemos, Henrique
    Barron-Millar, Ben
    Carey, Christopher
    Herron, Ian
    Anderson, Amy E.
    Mellor, Andrew L.
    Isaacs, John D.
    Pratt, Arthur G.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (10) : 1820 - 1830
  • [47] Therapeutic potential of Oroxylin A in rheumatoid arthritis
    Wang, Yu-ling
    Gao, Ju-mei
    Xing, Li-Zhi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 40 : 294 - 299
  • [48] Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
    Fukuda, Shin
    Kohsaka, Hitoshi
    Takayasu, Aiko
    Yokoyama, Waka
    Miyabe, Chie
    Miyabe, Yoshishige
    Harigai, Masayoshi
    Miyasaka, Nobuyuki
    Nanki, Toshihiro
    BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [49] Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl- secretion
    Matos, J. E.
    Sausbier, M.
    Beranek, G.
    Sausbier, U.
    Ruth, P.
    Leipziger, J.
    ACTA PHYSIOLOGICA, 2007, 189 (03) : 251 - 258
  • [50] Cardamonin Is a Bifunctional Vasodilator that Inhibits Cav1.2 Current and Stimulates KCa1.1 Current in Rat Tail Artery Myocytes
    Fusi, Fabio
    Cavalli, Maurizio
    Mulholland, Dulcie
    Crouch, Neil
    Coombes, Phil
    Dawson, Gill
    Bova, Sergio
    Sgaragli, Giampietro
    Saponara, Simona
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (02) : 531 - 540
12345